osiris therapeutics inc
(OSIR:Consolidated Issue listed on NASDAQ Global Market)
Michelle LeRoux Williams Ph.D.
Former Chief Scientific Officer, Osiris Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 1 different industries.|
As of Fiscal Year 2013
Dr. Michelle LeRoux Williams, Ph.D served as the Chief Scientific Officer of Osiris Therapeutics, Inc. from May 2007 to April 15, 2014. Dr. Williams served as Vice President of Development of Osiris Therapeutics, Inc. since May 2007. Dr. Williams joined Osiris in 2001 as the Director of Orthopedics and was responsible for the development of Osteocel from the initial concept through product launch in 2005. Dr. Williams also advanced the Chondrogen program from preclinical ...
7015 Albert Einstein DrivePhone: 443-545-1800
Columbia, Maryland 21046
Board Members Memberships*There is no Board Members Memberships data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Dominick C. Colangelo Esq.||Chief Executive Officer, President, Treasurer and Director|
|Michael D. West Ph.D.||Chief Executive Officer, President and Director|
|Thomas Axelsson M.Sc.||Chief Executive Officer|
Vitrolife AB (publ)
|Paul K. Wotton Ph.D.||Chief Executive Officer, President, Director and Member of Pricing Committee|
Ocata Therapeutics, Inc.
|Keith Murphy||Chairman, Chief Executive Officer, President, Member of Audit Committee and Member of Science & Technology Committee|
Organovo Holdings, Inc.
|$362.9K||Compensation as of Fiscal Year 2014.|